Gregory Fraser
Stock Analyst at Truist Securities
(2.66)
# 2,005
Out of 5,135 analysts
38
Total ratings
55.56%
Success rate
16.38%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Hold | $77 → $90 | $77.81 | +15.67% | 11 | Oct 9, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $220 → $230 | $168.72 | +36.32% | 1 | Mar 6, 2025 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $6.19 | +13.09% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $200 → $160 | $1.08 | +14,714.81% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $2.07 | +334.78% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $14.85 | -52.86% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $39.82 | -27.17% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $11.40 | +733.33% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $4.34 | +314.75% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $26.71 | +49.76% | 2 | May 26, 2023 |
ANI Pharmaceuticals
Oct 9, 2025
Maintains: Hold
Price Target: $77 → $90
Current: $77.81
Upside: +15.67%
Jazz Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $220 → $230
Current: $168.72
Upside: +36.32%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $6.19
Upside: +13.09%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200 → $160
Current: $1.08
Upside: +14,714.81%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $2.07
Upside: +334.78%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $14.85
Upside: -52.86%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $39.82
Upside: -27.17%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $11.40
Upside: +733.33%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $4.34
Upside: +314.75%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $26.71
Upside: +49.76%